As of 2024-12-15, the Fair Value of Foghorn Therapeutics Inc. (FHTX) is -8.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.30 USD, the upside of Foghorn Therapeutics Inc. is -254.81%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -51.13 | -68.80 | -101.32 | -108.88 | -98.43 | -85.71 |
| YoY growth | -94.12% | -34.56% | -47.27% | -7.46% | 9.60% | -34.76% |
| Market Cap (mil) | 294.63 |
| P/E | |
| Forward P/E |
| EPS | -1.64 |
| Avg earnings growth rate | -34.76% |
| TTM earnings | -91.22 |